Adverse Events Related to Low Dose Atropine

Progressive myopia can lead to severe vision loss and is associated with retinal detachment, glaucoma, and other comorbidities. Several studies have shown that off-label low-dose atropine eye drops slow the progression of myopia. Many eye care providers are now prescribing off-label atropine eye drops for their myopic patients, with varying concentrations amongst providers.The purpose of this study is to determine if low-dose atropine eyedrops used daily, cause adverse effects to the eyes. Patients currently using 0.01%, 0.03%, or 0.05% atropine eye drops obtained from compounding pharmacies will be assessed for associated adverse effects using a questionnaire.

Inclusion Criteria:Myopic patients currently using 0.01%, 0.03%, or 0.05% atropine eye drops, prescribed by the investigator.Exclusion Criteria: None